Media Statement: United States Tariffs on Australian Pharmaceuticals

3 April 2026 • via anneruston.com.au


AI Summary
  • The Coalition opposes the US's decision to impose a 100% tariff on Australian pharmaceuticals, threatening the $2 billion export industry.
  • Concerns about medicine availability and pricing have been raised with the Albanese Government, which has not acted decisively.
  • The Coalition calls for urgent action to secure an exemption for Australian exporters and to protect the Pharmaceutical Benefits Scheme.

The Coalition strongly opposes the United States’ decision to impose a sweeping 100 per cent tariff on Australian pharmaceuticals.

This announcement is deeply alarming because it poses a serious threat to our $2 billion pharmaceutical export industry, local medical innovation and, most concerningly, the cost and availability of medicines right here in Australia.

The Albanese Labor Government has been warned repeatedly but chose to put its head in the sand.

Medicine companies have been raising concerns about this issue with Labor for months but it remains unclear what action, if any, the Government has taken to secure an exemption or advocate for the interests of Australians.

On 18 April 2025, the Coalition wrote to the Prime Minister calling for a comprehensive submission to the United States’ Section 232 investigation into pharmaceutical imports. That was nearly a year ago. Australians deserve to know whether any action followed.

The Government must now act urgently to secure an exemption for Australian exporters. That must be the first priority.

For more than 20 years, Australian pharmaceutical exporters have operated tariff-free under the Australia–United States Free Trade Agreement secured by a former Coalition Government – an agreement negotiated without impacting the Pharmaceutical Benefits Scheme.

Let’s be clear: Australia’s Pharmaceutical Benefits Scheme must always be protected and is not up for negotiation, full stop.

At the same time, Mark Butler went on national television this morning and said medicine prices won't go up. But Australia imports about 90 per cent of medicines so any shift in global pharma trade creates real risks on price, on availability, or both.

Minister Butler needs to explain how the Albanese Government plans to protect Australians from any increase in the cost of medicines, particularly in the middle of a cost-of-living crisis.

This is the same government that told Australians there was nothing to worry about with fuel security. Australians are still living with the consequences of that complacency that we cannot afford.

The Coalition stands ready to work with the Government to secure an exemption and protect medicines for Australians, but there can be no more delays in acting.

ENDS

  • avatar of Anne Ruston AR

    Anne Ruston
    LP Federal

    Shadow Minister for Health and Aged Care

Mentions

  • avatar of Mark Butler MB

    Mark Butler
    ALP Federal

    Minister for Health and Ageing
  • Pharmaceutical Benefits Scheme Federal

    PBS